Expesicor Email Format
BiotechnologyMontana, United States2-10 Employees
Expesicor is a privately held biotechnology research company based in Kalispell, Montana, focused on preventing, treating, and curing neurological disorders. It pursues novel disease mechanisms through proprietary methods, including the KaL model of neurodegeneration and epilepsy. The company maintains a patent portfolio and positions itself as a holder of intellectual property in its field. Its work targets academic researchers and biopharmaceutical partners seeking new epilepsy therapies and broader neurological disorder interventions. In 2020, Expesicor announced a collaboration with Massachusetts General Hospital in Boston to advance its research. The company is small, with a compact team, and focuses on developing laboratory models of drug-resistant epilepsy to support drug discovery.